{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:51:15Z","timestamp":1791834675294,"version":"4.3.4"},"reference-count":143,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.canlet.2011.02.006","type":"journal-article","created":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T14:01:37Z","timestamp":1299333697000},"page":"150-162","source":"Crossref","is-referenced-by-count":164,"title":["Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma"],"prefix":"10.1016","volume":"305","author":[{"given":"Thomas S.","family":"Uldrick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Whitby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2011.02.006_b0005","series-title":"Symposium on Kaposi\u2019s Sarcoma","article-title":"Geographical and racial differences in the frequency of Kaposi\u2019s Sarcoma as evidence of environmental or genetic causes","author":"Oettle","year":"1962"},{"key":"10.1016\/j.canlet.2011.02.006_b0010","first-page":"155","article-title":"Development of cancer in transplantation patients","volume":"12","author":"Penn","year":"1978","journal-title":"Adv. Surg."},{"key":"10.1016\/j.canlet.2011.02.006_b0015","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1126\/science.7997879","article-title":"Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi\u2019s Sarcoma","volume":"266","author":"Chang","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.canlet.2011.02.006_b0020","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199505043321802","article-title":"Kaposi\u2019s Sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas","volume":"332","author":"Cesarman","year":"1995","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.canlet.2011.02.006_b0025","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1182\/blood.V86.4.1276.bloodjournal8641276","article-title":"Kaposi\u2019s Sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman\u2019s disease","volume":"86","author":"Soulier","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2011.02.006_b0030","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00002030-200103300-00013","article-title":"Decreasing rates of Kaposi\u2019s Sarcoma and non-Hodgkin\u2019s lymphoma in the era of potent combination anti-retroviral therapy","volume":"15","author":"Grulich","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.canlet.2011.02.006_b0035","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/sj.bjc.6604520","article-title":"Kaposi Sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy","volume":"99","author":"Franceschi","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2011.02.006_b0040","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1056\/NEJMc070508","article-title":"HIV-associated Kaposi\u2019s Sarcoma with a high CD4 count and a low viral load","volume":"357","author":"Maurer","year":"2007","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.canlet.2011.02.006_b0045","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1056\/NEJMc072994","article-title":"More on HIV-associated Kaposi\u2019s Sarcoma","volume":"358","author":"Krown","year":"2008","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.canlet.2011.02.006_b0050","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0140-6736(95)90780-7","article-title":"Kaposi\u2019s-Sarcoma-associated herpesvirus in HIV-negative Kaposi\u2019s Sarcoma","volume":"345","author":"Boshoff","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2011.02.006_b0055","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(95)90642-8","article-title":"Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi\u2019s Sarcoma","volume":"345","author":"Dupin","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2011.02.006_b0060","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/archinte.1996.00440020112014","article-title":"Kaposi\u2019s Sarcoma-associated herpesvirus and Kaposi\u2019s Sarcoma in Africa. Uganda Kaposi\u2019s Sarcoma Study Group","volume":"156","author":"Chang","year":"1996","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.canlet.2011.02.006_b0065","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00002030-199602000-00007","article-title":"Kaposi\u2019s Sarcoma-associated herpesvirus infection prior to onset of Kaposi\u2019s Sarcoma","volume":"10","author":"Moore","year":"1996","journal-title":"AIDS"},{"key":"10.1016\/j.canlet.2011.02.006_b0070","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/aje\/kwn125","article-title":"Early childhood infection by human herpesvirus 8 in Zambia and the role of human immunodeficiency virus type 1 coinfection in a highly endemic area","volume":"168","author":"Minhas","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.canlet.2011.02.006_b0075","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0140-6736(96)03240-0","article-title":"Antibodies to human herpesvirus type 8 in the general population and in Kaposi\u2019s Sarcoma patients","volume":"348","author":"Lennette","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2011.02.006_b0080","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0140-6736(96)07560-5","article-title":"Prevalence of Kaposi\u2019s Sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen","volume":"348","author":"Simpson","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2011.02.006_b0720","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nm0896-925","article-title":"KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi\u2019s sarcoma","volume":"2","author":"Gao","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2011.02.006_b0725","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jim.2010.02.015","article-title":"Detection of antibodies to Kaposi\u2019s sarcoma-associated herpesvirus: A new approach using K8.1 ELISA and a newly developed recombinant LANA ELISA","volume":"356","author":"Mbisa","year":"2010","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.canlet.2011.02.006_b0095","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1128\/JCM.38.6.2174-2180.2000","article-title":"Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection","volume":"38","author":"Spira","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.canlet.2011.02.006_b0100","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1046\/j.1537-2995.2003.00490.x","article-title":"Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors","volume":"43","author":"Pellett","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.canlet.2011.02.006_b0105","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1128\/CVI.00474-08","article-title":"Four-antigen mixture containing v-cyclin for serological screening of human herpesvirus 8 infection","volume":"16","author":"Burbelo","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.canlet.2011.02.006_b0110","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1056\/NEJM199804023381403","article-title":"Sexual transmission and the natural history of human herpesvirus 8 infection","volume":"338","author":"Martin","year":"1998","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.canlet.2011.02.006_b0115","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1086\/314926","article-title":"Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual sex","volume":"180","author":"Smith","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.canlet.2011.02.006_b0120","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/ijc.22281","article-title":"Risk factors for human Herpesvirus 8 infection and AIDS-associated Kaposi\u2019s Sarcoma among men who have sex with men in a European multicentre study","volume":"120","author":"Martro","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2011.02.006_b0125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1099\/vir.0.19465-0","article-title":"Genotypic characterization of Kaposi\u2019s Sarcoma-associated herpesvirus in asymptomatic infected subjects from isolated populations","volume":"85","author":"Whitby","year":"2004","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.canlet.2011.02.006_b0130","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3201\/eid1504.081488","article-title":"Seroprevalence of Kaposi Sarcoma-associated herpesvirus and other serologic markers in the Brazilian Amazon","volume":"15","author":"Nascimento","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.canlet.2011.02.006_b0135","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijid.2005.02.004","article-title":"Epidemiology and clinical characteristics of classic Kaposi\u2019s Sarcoma, seroprevalence, and variants of human herpesvirus 8 in South America: a critical review of an old disease","volume":"9","author":"Mohanna","year":"2005","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.canlet.2011.02.006_b0140","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1046\/j.1440-1827.2001.01293.x","article-title":"Classic type of Kaposi\u2019s Sarcoma and human herpesvirus 8 infection in Xinjiang","volume":"51","author":"Dilnur","year":"2001","journal-title":"China. Pathol. Int."},{"key":"10.1016\/j.canlet.2011.02.006_b0145","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1086\/598523","article-title":"Geographic variation in the prevalence of Kaposi Sarcoma-associated herpesvirus and risk factors for transmission","volume":"199","author":"de Sanjose","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.canlet.2011.02.006_b0150","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jmv.20730","article-title":"Human herpesvirus 8: serovprevalence and correlates in tumor patients from Xinjiang","volume":"79","author":"He","year":"2007","journal-title":"China. J. Med. Virol."},{"key":"10.1016\/j.canlet.2011.02.006_b0155","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jinf.2006.10.046","article-title":"HHV-8 seroprevalence in blood donors and HIV-positive individuals in Shandong area, China","volume":"55","author":"Mei","year":"2007","journal-title":"J. Infect."},{"key":"10.1016\/j.canlet.2011.02.006_b0160","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1743-422X-7-62","article-title":"Human herpesvirus-8 in northwestern China: epidemiology and characterization among blood donors","volume":"7","author":"Wang","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.canlet.2011.02.006_b0165","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1673-8527(08)60087-9","article-title":"Genotypic analysis on the ORF-K1 gene of human herpesvirus 8 from patients with Kaposi\u2019s Sarcoma in Xinjiang, China","volume":"35","author":"Zhang","year":"2008","journal-title":"J. Genet. Genom."},{"key":"10.1016\/j.canlet.2011.02.006_b0170","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jcv.2007.11.018","article-title":"Kaposi\u2019s Sarcoma-associated herpesvirus (KSHV) infection: endemic strains and cladograms from immunodeficient patients in China","volume":"42","author":"Zhu","year":"2008","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.canlet.2011.02.006_b0175","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/oxfordjournals.aje.a010196","article-title":"Invited commentary: determining specific sexual practices associated with human herpesvirus 8 transmission","volume":"151","author":"Martin","year":"2000","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.canlet.2011.02.006_b0180","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/QAI.0b013e31802f12ea","article-title":"Transmission of Kaposi Sarcoma-associated herpesvirus between mothers and children in a South African population","volume":"44","author":"Malope","year":"2007","journal-title":"J. Acq. Immune Def. Synd."},{"key":"10.1016\/j.canlet.2011.02.006_b0185","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1097\/00002030-200212060-00014","article-title":"Transmission of human herpesvirus 8 by sexual activity among adults in Lagos, Nigeria","volume":"16","author":"Eltom","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.canlet.2011.02.006_b0190","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1097\/00002030-200210180-00013","article-title":"Correlates of human herpesvirus 8 seropositivity among heterosexual men in Kenya","volume":"16","author":"Baeten","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.canlet.2011.02.006_b0195","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/jmv.20242","article-title":"Epidemiological characteristics of human herpesvirus-8 infection in a large population of antenatal women in Zambia","volume":"75","author":"Klaskala","year":"2005","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.canlet.2011.02.006_b0200","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/QAD.0b013e3282f46582","article-title":"No evidence of sexual transmission of Kaposi\u2019s Sarcoma herpes virus in a heterosexual South African population","volume":"22","author":"Malope","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.canlet.2011.02.006_b0205","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1086\/518791","article-title":"Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission","volume":"196","author":"Engels","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.canlet.2011.02.006_b0210","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1086\/598978","article-title":"Lack of evidence for frequent heterosexual transmission of human herpesvirus 8 in Zimbabwe","volume":"48","author":"Campbell","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.canlet.2011.02.006_b0215","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(95)91619-9","article-title":"Detection of Kaposi Sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi\u2019s Sarcoma","volume":"346","author":"Whitby","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2011.02.006_b0220","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1086\/424489","article-title":"Detection of Kaposi Sarcoma-associated herpesvirus DNA in saliva and buffy-coat samples from children with sickle cell disease in Uganda","volume":"190","author":"Mbulaiteye","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.canlet.2011.02.006_b0225","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/jnci\/djg039","article-title":"Human herpesvirus 8 infection and transfusion history in children with sickle-cell disease in Uganda","volume":"95","author":"Mbulaiteye","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2011.02.006_b0230","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.0041-1132.2005.04334.x","article-title":"Possible transmission of human herpesvirus-8 by blood transfusion in a historical United States cohort","volume":"45","author":"Dollard","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.canlet.2011.02.006_b0235","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1056\/NEJMoa055009","article-title":"Transmission of human herpesvirus 8 by blood transfusion","volume":"355","author":"Hladik","year":"2006","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.canlet.2011.02.006_b0240","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.0041-1132.2005.05008.x","article-title":"Human herpesvirus-8: what (not) to do?","volume":"45","author":"Dodd","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.canlet.2011.02.006_b0245","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1111\/j.1537-2995.2009.02269.x","article-title":"Quantitation of human herpesvirus 8 (HHV-8) antibody in patients transfused with HHV-8-seropositive blood","volume":"49","author":"Fowlkes","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.canlet.2011.02.006_b0250","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00002030-200301240-00012","article-title":"Risk factors for Kaposi\u2019s Sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus","volume":"17","author":"Cannon","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.canlet.2011.02.006_b0255","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/jmv.10548","article-title":"Comparison of human herpesvirus 8 and Epstein-Barr virus seropositivity among children in areas endemic and non-endemic for Kaposi\u2019s Sarcoma","volume":"72","author":"Martro","year":"2004","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.canlet.2011.02.006_b0260","first-page":"245","article-title":"KSHV after an organ transplant: should we screen?","volume":"312","author":"Marcelin","year":"2007","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.canlet.2011.02.006_b0265","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1111\/j.1600-6143.2009.02816.x","article-title":"The impact of preexisting or acquired Kaposi Sarcoma herpesvirus infection in kidney transplant recipients on morbidity and survival","volume":"9","author":"Frances","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.canlet.2011.02.006_b0270","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1086\/340817","article-title":"Risk factors for human herpesvirus 8 infection in a cohort of drug users in the Netherlands, 1985\u20131996","volume":"185","author":"Renwick","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.canlet.2011.02.006_b0275","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00007435-200303000-00004","article-title":"Factors associated with human herpesvirus type 8 infection in an injecting drug user cohort","volume":"30","author":"Bernstein","year":"2003","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.canlet.2011.02.006_b0280","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM200103013440904","article-title":"Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection","volume":"344","author":"Cannon","year":"2001","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.canlet.2011.02.006_b0285","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1086\/368332","article-title":"Seroprevalence of human herpesvirus 8 among injection drug users in San Francisco","volume":"187","author":"Atkinson","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.canlet.2011.02.006_b0290","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1054\/bjoc.1999.0983","article-title":"Detection of antibodies to human herpesvirus 8 in Italian children: evidence for horizontal transmission","volume":"82","author":"Whitby","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2011.02.006_b0295","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/01.qai.0000132495.89162.c0","article-title":"Water, socioeconomic factors, and human herpesvirus 8 infection in Ugandan children and their mothers","volume":"38","author":"Mbulaiteye","year":"2005","journal-title":"J. Acq. Immune Def. Synd."},{"key":"10.1016\/j.canlet.2011.02.006_b0300","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1086\/423326","article-title":"Mother-to-child transmission of human herpesvirus-8 in South Africa","volume":"190","author":"Dedicoat","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.canlet.2011.02.006_b0305","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1086\/520549","article-title":"Human herpesvirus-8 infection and oral shedding in Amerindian and non-Amerindian populations in the Brazilian Amazon region","volume":"196","author":"de Souza","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.canlet.2011.02.006_b0310","doi-asserted-by":"crossref","first-page":"8782","DOI":"10.1158\/0008-5472.CAN-04-2000","article-title":"M. van Beveren, P. Tortevoye, A. Froment, A. Gessain, Respective roles of serological status and blood specific antihuman herpesvirus 8 antibody levels in human herpesvirus 8 intrafamilial transmission in a highly endemic area","volume":"64","author":"Plancoulaine","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.02.006_b0315","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1086\/600103","article-title":"Kaposi Sarcoma-associated herpesvirus (KSHV) seroprevalence in population-based samples of African children: evidence for at least 2 patterns of KSHV transmission","volume":"200","author":"Butler","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.canlet.2011.02.006_b0320","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/ng1384","article-title":"Kaposi Sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi Sarcoma","volume":"36","author":"Wang","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2011.02.006_b0325","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1746-1596-3-31","article-title":"Histological variants of cutaneous Kaposi Sarcoma","volume":"3","author":"Grayson","year":"2008","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.canlet.2011.02.006_b0330","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/oxfordjournals.jncimonographs.a024176","article-title":"Kaposi\u2019s Sarcoma-associated herpesvirus-encoded oncogenes and oncogenesis","author":"Moore","year":"1998","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"10.1016\/j.canlet.2011.02.006_b0335","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.canlet.2009.07.004","article-title":"Kaposi Sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis","volume":"289","author":"Wen","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2011.02.006_b0340","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/jama.1969.03150210077009","article-title":"Disseminated visceral Kaposi\u2019s Sarcoma. Appearance after human renal homograft operation","volume":"207","author":"Siegel","year":"1969","journal-title":"JAMA"},{"key":"10.1016\/j.canlet.2011.02.006_b0345","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1002\/1097-0142(197812)42:6<2626::AID-CNCR2820420618>3.0.CO;2-7","article-title":"Association of Kaposi\u2019s Sarcoma and prior immunosuppressive therapy: a 5-year material of Kaposi\u2019s Sarcoma in Norway","volume":"42","author":"Klepp","year":"1978","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2011.02.006_b0350","unstructured":"Kaposi\u2019s Sarcoma and Pneumocystis pneumonia among homosexual men--New York City and California, MMWR Morb Mortal Wkly Rep 30 (1981) 305\u2013308."},{"key":"10.1016\/j.canlet.2011.02.006_b0355","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ijc.23487","article-title":"Cancer risk in people infected with human immunodeficiency virus in the United States","volume":"123","author":"Engels","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2011.02.006_b0360","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/jnci\/djm010","article-title":"AIDS-related cancer and severity of immunosuppression in persons with AIDS","volume":"99","author":"Biggar","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2011.02.006_b0365","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1002\/cncr.22236","article-title":"Virologic, hematologic, and immunologic risk factors for classic Kaposi Sarcoma","volume":"107","author":"Brown","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2011.02.006_b0370","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1086\/507648","article-title":"Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi Sarcoma","volume":"194","author":"Guihot","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.canlet.2011.02.006_b0375","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/QAD.0b013e328182df03","article-title":"Kaposi\u2019s Sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART\/chemotherapy in HIV clade C-infected individuals with Kaposi\u2019s Sarcoma","volume":"21","author":"Bihl","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.canlet.2011.02.006_b0380","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/TP.0b013e318184112c","article-title":"Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi Sarcoma","volume":"86","author":"Barozzi","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.canlet.2011.02.006_b0385","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa042831","article-title":"Sirolimus for Kaposi\u2019s Sarcoma in renal-transplant recipients","volume":"352","author":"Stallone","year":"2005","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.canlet.2011.02.006_b0390","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ccr.2006.05.026","article-title":"The TSC2\/mTOR pathway drives endothelial cell transformation induced by the Kaposi\u2019s Sarcoma-associated herpesvirus G protein-coupled receptor","volume":"10","author":"Sodhi","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2011.02.006_b0395","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1038\/leu.2009.117","article-title":"Targeting the mammalian target of rapamycin to inhibit VEGF and cytokines for the treatment of primary effusion lymphoma","volume":"23","author":"Gasperini","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2011.02.006_b0400","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1182\/blood-2006-06-028092","article-title":"Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling","volume":"109","author":"Sin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2011.02.006_b0405","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.immuni.2008.08.012","article-title":"The TSC-mTOR signaling pathway regulates the innate inflammatory response","volume":"29","author":"Weichhart","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2011.02.006_b0410","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1615\/CritRevImmunol.v27.i5.10","article-title":"Treatment of AIDS-related Kaposi\u2019s Sarcoma with interleukin-12: rationale and preliminary evidence of clinical activity","volume":"27","author":"Yarchoan","year":"2007","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.canlet.2011.02.006_b0415","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1182\/blood-2005-11-4455","article-title":"Activity of subcutaneous interleukin-12 in AIDS-related Kaposi Sarcoma","volume":"107","author":"Little","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2011.02.006_b0420","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/archderm.141.11.1421","article-title":"Association of clinical progression in classic Kaposi\u2019s Sarcoma with reduction of peripheral B lymphocytes and partial increase in serum immune activation markers","volume":"141","author":"Stratigos","year":"2005","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.canlet.2011.02.006_b0425","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ijc.11601","article-title":"Nadir B cell counts are significantly correlated with the risk of Kaposi\u2019s Sarcoma","volume":"108","author":"Stebbing","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2011.02.006_b0430","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1086\/386371","article-title":"Reduced levels of neutralizing antibodies to Kaposi Sarcoma-associated herpesvirus in persons with a history of Kaposi Sarcoma","volume":"189","author":"Kimball","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.canlet.2011.02.006_b0435","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1200\/JCO.2007.10.6732","article-title":"Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman\u2019s disease: ANRS 117 CastlemaB Trial","volume":"25","author":"Gerard","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2011.02.006_b0440","doi-asserted-by":"crossref","first-page":"836","DOI":"10.7326\/0003-4819-147-12-200712180-00003","article-title":"Brief communication: rituximab in HIV-associated multicentric Castleman disease","volume":"147","author":"Bower","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.canlet.2011.02.006_b0445","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.2643161","article-title":"AIDS-Kaposi\u2019s Sarcoma-derived cells express cytokines with autocrine and paracrine growth effects","volume":"243","author":"Ensoli","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.canlet.2011.02.006_b0450","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.4049\/jimmunol.158.10.4992","article-title":"Vascular endothelial growth factor is a potent angiogenic factor in AIDS-associated Kaposi\u2019s Sarcoma-derived spindle cells","volume":"158","author":"Nakamura","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2011.02.006_b0455","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1073\/pnas.94.3.979","article-title":"Vascular endothelial growth factor\/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi Sarcoma","volume":"94","author":"Masood","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2011.02.006_b0460","first-page":"1065","article-title":"Strong expression of kinase insert domain-containing receptor, a vascular permeability factor\/vascular endothelial growth factor receptor in AIDS-associated Kaposi\u2019s Sarcoma and cutaneous angiosarcoma","volume":"148","author":"Brown","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2011.02.006_b0465","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0002-9440(10)64344-1","article-title":"Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor\/vascular endothelial growth factor receptor","volume":"160","author":"Masood","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2011.02.006_b0470","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1172\/JCI119344","article-title":"Cytokine signaling through the novel tyrosine kinase RAFTK in Kaposi\u2019s Sarcoma cells","volume":"99","author":"Liu","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2011.02.006_b0475","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1046\/j.1523-1747.1999.00798.x","article-title":"Vascular endothelial growth factor-C (VEGF-C) and its receptors KDR and flt-4 are expressed in AIDS-associated Kaposi\u2019s Sarcoma","volume":"113","author":"Skobe","year":"1999","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.canlet.2011.02.006_b0480","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.96.8.4546","article-title":"E. van Marck, D. Salmon, I. Gorin, J.P. Escande, R.A. Weiss, K. Alitalo, C. Boshoff, Distribution of human herpesvirus-8 latently infected cells in Kaposi\u2019s Sarcoma, multicentric Castleman\u2019s disease, and primary effusion lymphoma","volume":"96","author":"Dupin","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2011.02.006_b0485","first-page":"1599","article-title":"Lymphatic endothelium and Kaposi\u2019s Sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3","volume":"58","author":"Jussila","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.02.006_b0490","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/34193","article-title":"G-protein-coupled receptor of Kaposi\u2019s Sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator","volume":"391","author":"Bais","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2011.02.006_b0495","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/JVI.77.1.57-67.2003","article-title":"The Kaposi\u2019s Sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells","volume":"77","author":"Cannon","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2011.02.006_b0500","first-page":"4873","article-title":"The Kaposi\u2019s Sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha","volume":"60","author":"Sodhi","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.02.006_b0505","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1535-6108(03)00024-2","article-title":"Kaposi\u2019s Sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2\/KDR","volume":"3","author":"Bais","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2011.02.006_b0510","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1182\/blood.V93.12.4034","article-title":"Angiogenesis and hematopoiesis induced by Kaposi\u2019s Sarcoma-associated herpesvirus-encoded interleukin-6","volume":"93","author":"Aoki","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2011.02.006_b0515","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/jnci\/94.12.926","article-title":"Tumorigenesis and aberrant signaling in transgenic mice expressing the human herpesvirus-8 K1 gene","volume":"94","author":"Prakash","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2011.02.006_b0520","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1182\/blood-2004-07-2781","article-title":"Activation of Src kinase Lyn by the Kaposi Sarcoma-associated herpesvirus K1 protein: implications for lymphomagenesis","volume":"105","author":"Prakash","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2011.02.006_b0525","doi-asserted-by":"crossref","first-page":"10413","DOI":"10.1128\/JVI.00611-07","article-title":"A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi\u2019s Sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia","volume":"81","author":"Cai","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2011.02.006_b0530","doi-asserted-by":"crossref","first-page":"7965","DOI":"10.1128\/JVI.00689-06","article-title":"Kaposi\u2019s Sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: latency control under low oxygen conditions","volume":"80","author":"Cai","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2011.02.006_b0535","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1097\/00002030-200308150-00015","article-title":"Detection and quantification of Kaposi\u2019s Sarcoma-associated herpesvirus to predict AIDS-associated Kaposi\u2019s Sarcoma","volume":"17","author":"Engels","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.canlet.2011.02.006_b0540","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1056\/NEJM199904083401402","article-title":"Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group","volume":"340","author":"Martin","year":"1999","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.canlet.2011.02.006_b0545","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1172\/JCI119380","article-title":"Sensitivity of Kaposi\u2019s Sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy","volume":"99","author":"Kedes","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2011.02.006_b0550","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1086\/346159","article-title":"A pilot study of cidofovir in patients with Kaposi Sarcoma","volume":"187","author":"Little","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.canlet.2011.02.006_b0555","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1182\/blood-2003-05-1721","article-title":"Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment","volume":"103","author":"Casper","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2011.02.006_b0730","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1086\/654798","article-title":"An IL-6-related systemic inflammatory syndrome in patients co-infected with Kaposi Sarcoma-associated herpesvirus and HIV but without multicentric Castleman disease","volume":"51","author":"Uldrick","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.canlet.2011.02.006_b0565","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1097\/00002030-199910220-00014","article-title":"Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi\u2019s Sarcoma","volume":"13","author":"Bower","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.canlet.2011.02.006_b0570","doi-asserted-by":"crossref","first-page":"F17","DOI":"10.1097\/00002030-200307250-00001","article-title":"A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi\u2019s Sarcoma","volume":"17","author":"Portsmouth","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.canlet.2011.02.006_b0575","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1258\/ijsa.2008.008372","article-title":"Increasing incidence of Kaposi\u2019s Sarcoma in black South Africans in KwaZulu-Natal, South Africa (1983\u20132006)","volume":"20","author":"Mosam","year":"2009","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.canlet.2011.02.006_b0580","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/ijc.21443","article-title":"Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS\u2013cancer registry match study","volume":"118","author":"Mbulaiteye","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2011.02.006_b0585","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/ijc.20606","article-title":"Treatment of AIDS-associated Kaposi\u2019s Sarcoma in Zimbabwe: results of a randomized quality of life focused clinical trial","volume":"113","author":"Olweny","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2011.02.006_b0590","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.qai.0000164033.02947.e3","article-title":"Survival after cancer diagnosis in persons with AIDS","volume":"39","author":"Biggar","year":"2005","journal-title":"J. Acq. Immune Def. Synd."},{"key":"10.1016\/j.canlet.2011.02.006_b0595","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1200\/JCO.2004.08.064","article-title":"Highly active antiretroviral therapy in AIDS-associated Kaposi\u2019s Sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi\u2019s Sarcoma","volume":"22","author":"Krown","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2011.02.006_b0600","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1097\/QAD.0b013e32832d080d","article-title":"The effect of HAART in 254 consecutive patients with AIDS-related Kaposi\u2019s Sarcoma","volume":"23","author":"Bower","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.canlet.2011.02.006_b0605","doi-asserted-by":"crossref","unstructured":"A. Mosam, F. Shaik, T. Uldrick, T. Esterhuizen, G. Friedland, D. Scadden, J. Aboobaker, H. Coovadia, The KAART Trial: a randomised controlled trial of HAART compared to the combination of HAART and chemotherapy in treatment naive patients with HIV-associated Kaposi\u2019s Sarcoma (HIV-KS) in KwaZulu-Natal (KZN), South Africa NCT 00380770, in: 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, 2010.","DOI":"10.1186\/1750-9378-5-S1-A80"},{"key":"10.1016\/j.canlet.2011.02.006_b0610","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nm0302-225","article-title":"HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi Sarcoma","volume":"8","author":"Sgadari","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2011.02.006_b0615","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/sj.bjc.6603056","article-title":"Remission from Kaposi\u2019s Sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy","volume":"94","author":"Martinez","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2011.02.006_b0620","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/QAD.0b013e3282ff6275","article-title":"Persistent Kaposi Sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response","volume":"22","author":"Nguyen","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.canlet.2011.02.006_b0625","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1128\/JVI.74.2.684-692.2000","article-title":"Human herpesvirus 8 open reading frame 21 is a thymidine and thymidylate kinase of narrow substrate specificity that efficiently phosphorylates zidovudine but not ganciclovir","volume":"74","author":"Gustafson","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2011.02.006_b0630","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.1158\/0008-5472.CAN-07-0939","article-title":"Hypoxia enhances the phosphorylation and cytotoxicity of ganciclovir and zidovudine in Kaposi\u2019s Sarcoma-associated herpesvirus infected cells","volume":"67","author":"Davis","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.02.006_b0635","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1200\/JCO.2005.14.597","article-title":"Immune reconstitution inflammatory syndrome associated with Kaposi\u2019s Sarcoma","volume":"23","author":"Bower","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2011.02.006_b0640","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1089\/apc.2005.19.635","article-title":"Recrudescent Kaposi\u2019s Sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome","volume":"19","author":"Leidner","year":"2005","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.canlet.2011.02.006_b0645","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QAI.0b013e3181bc476f","article-title":"Predictors of immune reconstitution inflammatory syndrome-associated with Kaposi Sarcoma in Mozambique: a prospective study","volume":"1","author":"Letang","year":"2009","journal-title":"J. Acq. Immune Def. Synd."},{"key":"10.1016\/j.canlet.2011.02.006_b0650","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJMp1002812","article-title":"Can we treat cancer for a dollar a day? Guidelines for low-income countries","volume":"363","author":"Kerr","year":"2010","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.canlet.2011.02.006_b0655","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1200\/JCO.1996.14.8.2353","article-title":"Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi\u2019s Sarcoma","volume":"14","author":"Gill","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2011.02.006_b0660","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1200\/JCO.1998.16.2.683","article-title":"Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi\u2019s Sarcoma. International pegylated liposomal doxorubicin study group","volume":"16","author":"Stewart","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2011.02.006_b0665","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1200\/JCO.1998.16.7.2445","article-title":"Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi\u2019s Sarcoma: results of a randomized phase III clinical trial","volume":"16","author":"Northfelt","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2011.02.006_b0670","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1081\/CNV-100104284","article-title":"Effect of treatment on health-related quality of life in acquired immunodeficiency syndrome (AIDS)-related Kaposi\u2019s Sarcoma: a randomized trial of pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine","volume":"19","author":"Osoba","year":"2001","journal-title":"Cancer Invest."},{"key":"10.1016\/j.canlet.2011.02.006_b0675","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1097\/01.aids.0000131385.60974.b9","article-title":"Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi\u2019s Sarcoma","volume":"18","author":"Martin-Carbonero","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.canlet.2011.02.006_b0680","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/589865","article-title":"Long-term prognosis of HIV-infected patients with Kaposi Sarcoma treated with pegylated liposomal doxorubicin","volume":"47","author":"Martin-Carbonero","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.canlet.2011.02.006_b0685","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0140-6736(95)92654-2","article-title":"Treatment of HIV-associated Kaposi\u2019s Sarcoma with paclitaxel","volume":"346","author":"Saville","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2011.02.006_b0690","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1200\/JCO.1999.17.6.1876","article-title":"Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi\u2019s Sarcoma","volume":"17","author":"Gill","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2011.02.006_b0695","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/01.qai.0000194237.15831.23","article-title":"Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi Sarcoma: an AIDS malignancy consortium phase I trial","volume":"41","author":"Krown","year":"2006","journal-title":"J. Acq. Immune Def. Synd."},{"key":"10.1016\/j.canlet.2011.02.006_b0700","first-page":"138","article-title":"Weekly oral etoposide in patients with Kaposi\u2019s Sarcoma associated with human immunodeficiency virus infection: a phase I multicenter trial of the AIDS Clinical Trials Group","volume":"9","author":"Paredes","year":"1995","journal-title":"J. Acq. Immune Def. Synd. Hum. Retrovirol."},{"key":"10.1016\/j.canlet.2011.02.006_b0705","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1200\/JCO.2000.18.13.2593","article-title":"Activity of Thalidomide in AIDS-Related Kaposi\u2019s Sarcoma","volume":"18","author":"Little","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2011.02.006_b0710","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1182\/blood-2007-06-097568","article-title":"Phase 2 study of pegylated liposomal doxorubicin in combination with interleukin-12 for AIDS-related Kaposi Sarcoma","volume":"110","author":"Little","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2011.02.006_b0715","unstructured":"T.S. Uldrick, K.M. Wyvill, P.P. Kumar, W. Bernstein, D.O. O\u2019Mahony, M.N. Polizzotto, K. Aleman, S.M. Steinberg, S. Pittaluga, R.F. Little, R. Yarchoan, A phase II study targeting vascular endothelial growth factor with the humanized monoclonal antibody Bevacizumab in the treatment of patients with HIV-associated Kaposi Sarcoma. Paper #31, in: 17th Conference on Retroviruses and Opportunistic Infections, San Fransisco, CA, 2010."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383511000681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383511000681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T14:25:57Z","timestamp":1685975157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383511000681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":143,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0304383511000681"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2011.02.006","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}